[1]. Burris KD, et al. Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther. 2002 Jul;302(1):381-9.
[2]. Davies MA, et al. Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology. CNS Drug Rev. 2004 Winter;10(4):317-36.
[3]. Crespo-Facorro B, et al. Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis. Front Pharmacol. 2021 Mar 2;12:646701.
[4]. Russo E, et al. Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology. 2013 Jan;64:371-9.
物理化学性质
分子式
C23H29Cl2N3O3
分子量
466.40100
精确质量
465.15900
PSA
57.53000
LogP
4.88300
合成线路
共1页
阿立哌唑
129722-12-9
~96%
7-[4-[4-(2,3-di...
851220-85-4
文献:BRISTOL-MYERS SQUIBB COMPANY Patent: WO2005/41970 A1, 2005 ; Location in patent: Page/Page column 7; 14 ;